Aarti Pharmalabs Limited — Call Transcript 2023

Aug 7, 2023

==> picture [137 x 53] intentionally omitted <==

August 07, 2023

To, Listing/ Compliance Department BSE LTD. Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001

SCRIP CODE: 543748

To, Listing/ Compliance Department National Stock Exchange of India Limited “Exchange Plaza”, Plot No. C/1, G Block, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051 SYMBOL: AARTIPHARM

Dear Sir/Madam,

Sub: Intimation of Conference Call Ref: Regulation 30(6) of the SEBI (LODR) Regulations 2015

This is to inform you that the Quarterly Earnings Conference Call for Investors and Analysts has been scheduled on Thursday, August 10, 2023 at 6:15 p.m. IST to discuss the Company's Q1 FY24 Results .

Please find attached herewith invitation for the same.

Kindly take the same on your record.

Thanking you,

Yours faithfully,

For AARTI PHARMALABS LIMITED

(Formerly known as Aarti Organics Limited)

NIKHIL Digitally signed by NIKHIL PANDURANG PANDURAN NATU Date: 2023.08.07 G NATU 16:36:36 +05'30'

NIKHIL NATU

COMPANY SECRETARY ICSI M. NO. A27738

Encl. a/a.

==> picture [452 x 59] intentionally omitted <==

==> picture [144 x 56] intentionally omitted <==

==> picture [198 x 127] intentionally omitted <==

Aarti Pharmalabs Limited’s Q1 FY24 Results Conference Call on Thursday, August 10, 2023 at 6:15 pm IST

Aarti Pharmalabs Limited, a leading Indian manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine Derivatives, with a global footprint, will organize a conference call for investors and analysts on Thursday, August 10, 2023 at 6:15 pm IST .

The conference call will be initiated with a brief management discussion on the Q1 FY24 results, followed by an interactive Question & Answer session. The management team will be represented by:

• Mr. Rashesh Gogri – Chairman

• Mrs. Hetal Gogri Gala – Vice Chairperson & Managing Director

• Mr. Piyush Lakhani – Chief Financial Officer

Details of the conference call are as follows:

Please dial the below number 5-10 minutes prior to the scheduled start to ensure that you are connected to the call in time.

Timing	6:15 pm IST on Thursday,August 10,2023
Conference dial-in
Primarynumber(India)	+91 22 6280 1141/+91 227115 8042
Singapore Toll FreeNumber	800 101 2045
HongKongToll Free Number	800 964 448
USA Toll Free Number	1 866746 2133
UK Toll Free Number	0 808 101 1573
	To enable participants to connect to the conference call without having to
	wait for an operator, please register at the below mentioned link:
Pre-registration
	You will receive dial in numbers, passcode and a pin for the concall on the
	registered email address provided by you. Kindly dial into the call on the
	ConferenceCall date and use thepasscode& pin to connect to call

For further information on the Company, please visit www.aartipharmalabs.com

Mr. Piyush Lakhani/ Mr. Nikhil Natu Aarti Pharmalabs Limited Tel : +91 22 6797 6666 Email: info@aartipharmalabs.com

DISCLAIMER:

Certain statements that may be made or discussed at the conference call may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like significant changes in economic environment in India and overseas, tax laws, import duties, litigation, labour relations etc. Actual results might differ substantially from those expressed or implied. Aarti Pharmalabs Ltd. will not be in any way responsible for any action taken based on such statements and discussions; and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.

==> picture [32 x 29] intentionally omitted <==

==> picture [31 x 29] intentionally omitted <==

Aarti Pharmalabs Limited CIN: L24100GJ2019PLC110964

2nd Floor, 204, Udyog Kshetra, Mulund - Goregaon Link Rd, Mulund (W), Mumbai, Maharashtra - 400 080.